Country: United States
Language: English
Source: NLM (National Library of Medicine)
FINASTERIDE (UNII: 57GNO57U7G) (FINASTERIDE - UNII:57GNO57U7G)
Avera McKennan Hospital
FINASTERIDE
FINASTERIDE 5 mg
PRESCRIPTION DRUG
Abbreviated New Drug Application
FINASTERIDE- FINASTERIDE TABLET, FILM COATED AVERA MCKENNAN HOSPITAL ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE FINASTERIDE SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR FINASTERIDE. FINASTERIDE TABLETS USP, 5 MG, FOR ORAL USE INITIAL U.S. APPROVAL: 1992 INDICATIONS AND USAGE Finasteride, is a 5α-reductase inhibitor, indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to (1.1): Improve symptoms Reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. Finasteride administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of symptomatic progression of BPH (a confirmed ≥4 point increase in American Urological Association (AUA) symptom score) (1.2). LIMITATIONS OF USE: Finasteride is not approved for the prevention of prostate cancer (1.3). DOSAGE AND ADMINISTRATION Finasteride may be administered with or without meals (2). Monotherapy: One tablet (5 mg) taken once a day (2.1). Combination with Doxazosin: One tablet (5 mg) taken once a day in combination with the alpha-blocker doxazosin (2.2). DOSAGE FORMS AND STRENGTHS 5-mg film-coated tablets (3). CONTRAINDICATIONS Hypersensitivity to any components of this product (4). Women who are or may potentially be pregnant (4, 5.4, 8.1, 16). WARNINGS AND PRECAUTIONS Finasteride reduces serum prostate specific antigen (PSA) levels by approximately 50%. However, any confirmed increase in PSA while on Finasteride may signal the presence of prostate cancer and should be evaluated, even if those values are still within the normal range for men not taking a 5α-reductase inhibitor (5.1). Finasteride may increase the risk of high-grade prostate cancer (5.2, 6.1). Women should not handle crushed or broken finasteride tablets when they are pregnant or may potentially be pregnant due to potential risk to a male fetus (5.3, 8.1, 16). Finasteride i Read the complete document